NCT06020534|CompletedResults
Aortoiliac Stenosis in Kidney Transplantation
TASC
Safety and Efficacy of Kidney Transplantation in Patients With Aortoiliac Stenosis
Loading search results
TASC
Safety and Efficacy of Kidney Transplantation in Patients With Aortoiliac Stenosis
Sponsor study identifier
observational
655
1 country
1
Study Start
January 1, 2022
Actual (reported)Primary Completion
January 31, 2023
Actual (reported)Study Completion
June 30, 2023
Actual (reported)The impact of aortoiliac stenosis on kidney transplant patients remains unclear. This study aims to investigate the safety and efficacy of kidney transplantation in patients with aortoiliac stenosis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2022
Actual (reported)January 31, 2023
Actual (reported)June 30, 2023
Actual (reported)August 24, 2023
Actual (reported)August 31, 2023
Actual (reported)December 12, 2024
Actual (reported)Patient Survival
Patient survival was calculated based on all-cause death from the date of kidney transplantation till the end of follow-up (January, 2023), assessed up to 10 years.
From the date of kidney transplantation till death or data cut-off, whichever came first, assessed up to 10 years.
Death-censored Graft Survival
From the date of kidney transplantation till death or data cut-off, whichever came first, assessed up to 10 years.
Graft Function
From the date of kidney transplantation till death or data cut-off, whichever came first, assessed up to 10 years.
Patients who had no pre-existing aortoiliac stenosis before kidney transplantation.
Patients who had TASC A or B aortoiliac stenosis before kidney transplantation.
Patients who had TASC C or D aortoiliac stenosis before kidney transplantation.
Patients who underwent kidney transplantation in the Erasmus Medical Center between January 2010 and December 2020.
Yitian Fang
Rotterdam, South Holland, 3015 GD, Netherlands
Fang Y, Hamm JJM, den Hartog FPJ, Kimenai HJAN, de Bruin RWF, Minnee RC. Safety and efficacy of kidney transplantation in patients with aortoiliac stenosis: a retrospective cohort study. Int J Surg. 2024 Feb 1;110(2):992-999. doi: 10.1097/JS9.0000000000000926.
Firstly, there is a guarantee for selection bias in patients with the most severe aortoiliac stenosis, as these patients might be rejected for kidney transplantation and would not be included in the study. Secondly, the study's single-center design could introduce institutional-specific practices that may not be universally applicable. Lastly, details of stenosis proximal or distal to the transplanted kidney were unknown.
Yitian Fang, MD
Erasmus Medical Center
655 participants (actual enrollment reported by the registry).
First Submitted
August 24, 2023
First Posted
August 31, 2023
Study Start
January 1, 2022
Actual (reported)Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.
Contact the study team to confirm eligibility.
Primary Completion
January 31, 2023
Actual (reported)Study Completion
June 30, 2023
Actual (reported)Last Updated
January 7, 2025
Results First Posted
December 12, 2024
Record last verified: 2024-12
The data that support this study are not publicly available due to reasons of sensitivity and are available from the principal investigator upon reasonable request.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: